Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Politics

Pfizer Plans 400% Price Increase for mRNA COVID Jab After CDC Panels Recommend to Include COVID Shots for Children and Adolescents Annual Immunization Schedule

by October 22, 2022
October 22, 2022
Pfizer Plans 400% Price Increase for mRNA COVID Jab After CDC Panels Recommend to Include COVID Shots for Children and Adolescents Annual Immunization Schedule

How convenient.

After CDC panels recommend adding COVID shots to children and adolescents’ annual immunization schedule, Pfizer plans to increase the price of their mRNA COVID jab by 400%.

Pfizer announced during an investor call that the company is considering charging between $110 and $130 per dosage for the private market for the COVID shot Comirnaty as government contracts come to an end.

The call was conducted on Thursday to review data on RSV and provide a commercial update on the company’s COVID vaccine. The investor call was uploaded on Thursday at 3:31 PM, hours after CDC panels voted to add the COVID vaccine to the annual immunization schedule for children and adolescents.

The new pricing will go into effect in 2023, most likely during the first quarter.

Pfizer shareholders are excited that they will charge 4X the price to private insurers than they did to our govt for the COVID vax. Govt paid $30/dose; private insurers will pay $120. Yesterday @CDCgov recommended for child vax schedule. Good for pharma, bad for our kids.

— Yiatin Chu (@ycinnewyork) October 21, 2022

Fierce Pharma reported:

Since vaccines became available in the U.S., the government has footed the bill and provided them for free. In the last supply contract the U.S. signed with Pfizer and BioNTech in June of this year, the companies charged $30.48 per dose, which was an increase from a $24 price in July of 2021 and $19.50 per dose in July of 2020.

“Based on our current understanding, when we enter a traditional commercial model, anyone with commercial or government insurance who is eligible to be vaccinated should be able to access the vaccine without any out-of-pocket payments,” Angela Lukin, Pfizer’s U.S. president of global primary care, said during the call.

One of the reasons for the increase, Pfizer said, is that it will provide vaccines in a single-dose vial as opposed to the current multi-dose vials. This change is because of “consumer preference,” Lukin said.

The price is not out of line with other vaccines that are provided to adults. It is more than what CVS, for example, charges for a flu shot ($50 or $95), but is less than many other vaccines including Pneumovax 23 ($141), hepatitis ($145), meningitis ($179), shingles ($205) and HPV ($261).

Moderna did not respond immediately to a question about how much it plans to charge for its COVID-19 vaccine Spikevax.

In justifying the price, Pfizer mentioned its “50/50 gross profit split” with BioNTech and the reinvestment cost as the company continues to beef up manufacturing and develop the vaccine as the virus evolves.

The post Pfizer Plans 400% Price Increase for mRNA COVID Jab After CDC Panels Recommend to Include COVID Shots for Children and Adolescents Annual Immunization Schedule appeared first on The Gateway Pundit.

0
FacebookTwitterGoogle +Pinterest
previous post
Steve Bannon in First Interview Following Sentencing Tells Tucker Carlson His Wish for the Country (VIDEO)
next post
BREAKING: Judge Grants MO AG Request to Depose Dr. Fauci, Jen Psaki, FBI Agent Elvis Chan, etc. in Social Media Collusion Case Featuring TGP’s Jim Hoft as Plaintiff

You may also like

Biden admin launches push to expand voter registration...

August 27, 2023

Harris paid Oprah $1 million in failed bid...

November 11, 2024

Reporter Asks John Kirby if He’s at ‘White...

September 16, 2022

Trump blasts American leaders as no US citizens...

November 26, 2023

House lawmakers visit Taiwan as China warns US...

May 26, 2024

FIGHTING BACK: State Treasurer Withdraws Nearly $800 Million...

October 6, 2022

Are the Chinese about to ‘deal a devastating...

May 1, 2024

The president who couldn’t quit: Jimmy Carter’s foreign...

January 7, 2025

Hamas leaders admit no interest in governing Gaza,...

November 9, 2023

Iran trying to sabotage Trump’s presidential campaign: US...

July 29, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Lunar Loussia’s Rise: From Family Storefronts to Business Scale-Up

      August 1, 2025
    • Trump takes jab at GOP senator, urging Republicans to ‘vote the exact opposite of’ how she does

      August 1, 2025
    • Tech’s Next Frontier: Preparing Your Business for the Quantum Computing Revolution

      August 1, 2025
    • Sewing Bee star Lauren Guthrie threads new growth into Birmingham business

      August 1, 2025
    • Anneliese Dodds urges Labour to consider wealth tax to plug public finance gap

      August 1, 2025
    • PM urged to review North Sea oil policy after Trump calls it UK’s ‘treasure chest’

      August 1, 2025

    Categories

    • Business (8,648)
    • Investing (2,165)
    • Politics (16,272)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved